Worsening of chronic post-hypoxic myoclonus (Lance-Adams syndrome) with functional decline following a decrease in the dose of levetiracetam (rebound effect): case report

    This is a preview of subscription content, log in to check access.


    1. Olsen DG, et al. Triple pharmacotherapy in the treatment of refractory chronic posthypoxic myoclonus (Lance-Adams syndrome): A case report. P M and R - The Journal of Injury, Function and Rehabilitation 11 (Suppl. 2): S133, Nov 2019. Available from: URL: http://doi.org/10.1002/pmrj.12271 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Levetiracetam. Reactions Weekly 1808, 176 (2020). https://doi.org/10.1007/s40278-020-79653-7

    Download citation